Single-cell analysis reveals differential regulation of the alveolar macrophage actin cytoskeleton by surfactant proteins A1 and A2: implications of sex and aging
© Tsotakos et al. 2016
Received: 2 November 2015
Accepted: 11 March 2016
Published: 18 March 2016
Surfactant protein A (SP-A) contributes to lung immunity by regulating inflammation and responses to microorganisms invading the lung. The huge genetic variability of SP-A in humans implies that this protein is highly important in tightly regulating the lung immune response. Proteomic studies have demonstrated that there are differential responses of the macrophages to SP-A1 and SP-A2 and that there are sex differences implicated in these responses.
Purified SP-A variants were used for administration to alveolar macrophages from SP-A knockout (KO) mice for in vitro studies, and alveolar macrophages from humanized SP-A transgenic mice were isolated for ex vivo studies. The actin cytoskeleton was examined by fluorescence and confocal microscopy, and the macrophages were categorized according to the distribution of polymerized actin.
In accordance with previous data, we report that there are sex differences in the response of alveolar macrophages to SP-A1 and SP-A2. The cell size and F-actin content of the alveolar macrophages are sex- and age-dependent. Importantly, there are different subpopulations of cells with differential distribution of polymerized actin. In vitro, SP-A2 destabilizes actin in female, but not male, mice, and the same tendency is observed by SP-A1 in cells from male mice. Similarly, there are differences in the distribution of AM subpopulations isolated from SP-A transgenic mice depending on sex and age.
There are marked sex- and age-related differences in the alveolar macrophage phenotype as illustrated by F-actin staining between SP-A1 and SP-A2. Importantly, the phenotypic switch caused by the different SP-A variants is subtle, and pertains to the frequency of the observed subpopulations, demonstrating the need for single-cell analysis approaches. The differential responses of alveolar macrophages to SP-A1 and SP-A2 highlight the importance of genotype in immune regulation and the susceptibility to lung disease and the need for development of individualized treatment options.
KeywordsSurfactant protein A Alveolar macrophages Actin cytoskeleton F-actin G-actin Single-cell imaging analysis Sex differences Age-related differences Immune response
Surfactant protein A (SP-A) is one of the many molecules that contribute to lung immunity. It binds foreign particles and organisms that invade the lungs and targets them for clearance via phagocytosis by the alveolar macrophages. It also enhances clearance of inflammatory cells after the inflammation has been resolved and finally gets removed by the alveolar macrophages themselves. The SP-A/alveolar macrophage interaction enhances the alveolar macrophage functions such as chemotaxis, chemokine and reactive oxidant production, phagocytosis, and endolysosomal trafficking.
SP-A knockout mice have extensively been used as a model to elucidate the role of SP-A in lung innate immunity. It has been shown that SP-A regulates inflammation following ozone exposure  and other lung challenges , while its absence leads to increased susceptibility to infection by many organisms, such as Klebsiella pneumoniae [3, 4], Pseudomonas aeruginosa , group B Streptococcus , and viruses . Humans, however, have two distinct SP-A genes, namely, SP-A1 and SP-A2, and a number of variants for each one, indicating that the roles of SP-A in immunity are complex and finely tuned. The different SP-A variant molecules display distinct functions, including, but not limited to, cytokine production [8, 9], phosphatidylcholine secretion , and phagocytic activity [11–13].
Previous studies performed in our laboratory showed that the proteome of alveolar macrophages from SP-A knockout (KO) mice treated with a single intrapharyngeal dose of SP-A resembles that of the wild-type mice  and there are sex differences in the response of the alveolar macrophage proteome to SP-A . The regulation of the alveolar macrophage phenotype by SP-A becomes more complex when one takes into account the fact that the proteomes of alveolar macrophages derived from humanized transgenic mice that express either SP-A1 or SP-A2 are significantly different  and that there are sex differences in the responses of the macrophage cellular proteomes to different SP-A variants .
The alveolar macrophages perform most of the search-and-destroy functions (chemotaxis and phagocytosis) in the lung. The actin cytoskeleton is a crucial mediator of these processes. Interestingly, the proteomic analyses mentioned above identified proteins that are related to the actin cytoskeleton as being differentially regulated by SP-A1 and SP-A2. In the present study, we performed a single-cell imaging analysis to determine the in vitro and ex vivo effects of SP-A1 and SP-A2 on the distribution of F-actin in the alveolar macrophages. Our findings demonstrate diverse roles of SP-A1 and SP-A2 in the regulation of the alveolar macrophage cytoskeleton and, hence, the cell’s motility and activation status.
All mice used in the present study were on the C57BL6/J background and were either 8 weeks (young) or 8–10 months (old) in age. SP-A KO and humanized transgenic SP-A1, SP-A2, and SP-A1/SP-A2 mice were generated on the C57BL6/J background . The animals were raised in the breeding facility of the Penn State College of Medicine. All the mice were maintained in a pathogen-free environment or in barrier facilities with free access to food and water. The study was approved by the Institutional Animal Care and Use Committee of the Penn State College of Medicine. For each experiment, equal numbers of age-matched males and females (n = 3) were used.
Collection of bronchoalveolar lavage fluid
Mice were euthanized using a mixture of ketamine and xylazine, and bronchoalveolar lavage (BAL) fluid was collected  by instilling 1 mM EDTA/PBS into the lungs through a tracheal cannula using 0.5 mL of solution five times, for a total of 2.5 mL. For each instillation, the solution was applied and withdrawn three times with concurrent chest massage. The BAL fluid was centrifuged at 150g for 5 min at 4 °C, and the cell pellet was washed once with 1 mL of 1 mM EDTA/PBS. Total cells were counted with the use of a hemocytometer, and cytocentrifuge slides were prepared for differential cell counting with the Fisher Healthcare Protocol Hema 3 stain (Fisher Scientific) according to the manufacturer’s instructions.
Culture of mAMs
Following collection of the BAL fluid, AMs were washed with serum-free RPMI-1640 containing 2 mM glutamine and 1× antibiotic-antimycotic solution. The AMs were then resuspended in the same medium and plated on UV-sterilized coverslips (No. 1, 18-mm diameter) in 12-well cell culture plates. After allowing the cells to attach for 90 min, the medium was changed and the cells were incubated overnight at 37 °C in the presence of 5 % CO2. In a set of experiments, the AMs were treated with 10 μg of SP-A1, 10 μg of SP-A2, 5 μg SP-A1 + 5 μg SP-A2, or 10 μg SP-A1 + 10 μg SP-A2 for 60 min before staining.
Preparation of purified SP-A
Purified SP-A was prepared from CHO cells as described previously . Briefly, stably transfected CHO-derived cell lines expressing either SP-A1 (6A2) or SP-A2 (1A0) were cultured for 5 days in the expression medium as described , and the conditioned media were collected. SP-A was purified using mannose affinity chromatography, concentrated, and stored at −80 °C until use. The concentration of lipopolysaccharides (LPS) in the SP-A preparations was measured using the Limulus Amebocyte Lysate QCL-1000 assay (Lonza, Walkersville, MA). LPS was below the detection limit of the assay in all the preparations used in the present study. Purity of SP-A was determined by silver staining (Bio-Rad Silver Stain Plus Kit, Bio-Rad).
Staining for F-actin, G-actin, and cell membranes
Following the overnight culture, the AMs were washed once with PBS, fixed with 3.7 % paraformaldehyde for 10 min at room temperature, permeabilized with 0.5 % Triton X-100, and washed three times before incubation for 30 min in staining solution, containing one unit of Alexa Fluor 488-conjugated phalloidin (Molecular Probes, Eugene, OR). In some experiments, the staining solution also contained 0.3 μM of Alexa Fluor 594-conjugated (deoxyribonuclease 1) DNase I and 5 μg/mL of Alexa Fluor 647-conjugated wheat germ agglutinin (Molecular Probes). Following three more washes, the coverslips were mounted on cover glasses with ProLong Gold Mounting Medium with DAPI (Life Technologies, Eugene, OR). Depending on the distribution of F-actin, the cells were blindly (without knowledge of the sex or the genotype of the animal) categorized as belonging to one of the four subpopulations: A, minimal F-actin staining; B, perinuclear F-actin staining; C, diffuse cytoplasmic F-actin; or D, existence of cytoplasmic protrusions (filopodia or podosomes).
Image acquisition and data analysis
For light microscopy experiments of F-actin staining, the mAMs were imaged using a Nikon TE-2000 PFS fluorescence microscope, using a ×60/1.40 phase contrast, oil immersion objective lens. The images were captured using a Photometrics Coolsnap HQ2 digital camera (0.11 μm/pixel) and saved as TIFF files. The acquisition time was 100 ms for all images acquired. Nikon NIS-Elements v.3.0 software was used for image acquisition, and Adobe Photoshop CD4 was used for image analysis. The AMs were analyzed by manually drawing an area around the border of each cell, and a cell-free area of equal size was used for background subtraction. The exported data included the average fluorescence per pixel, the number of pixels in each selected area (cell), and the sum of fluorescence intensity for each cell.
For confocal microscopy experiments (multicolor imaging), a Leica AOBS SP8 laser scanning confocal imaging microscope (Leica, Heidelberg, Germany) at the Penn State College of Medicine Imaging Core was used. Images were acquired using a high-resolution Leica ×60/1.3 Plan-Apochromat oil immersion objective lens. The laser lines were produced by a UV diode (for DAPI) and an 80-MHz white light laser (Leica SP8 AOBS module, for Alexa Fluor conjugates). The emission signals were collected sequentially using acousto-optical beamsplitter (AOBS) tunable filters using a pinhole Airy size of 1.0. The bandwidths of the highly sensitive HyD detectors were set in a way that prevented fluorescence bleed-through. The images were obtained with the use of the Leica Application Suite (LAS AF), and image analysis was performed using the Imaris v.7.3 software (Bitplane). The fluorescent signals were rendered with the Surface tool in the Surpass View of the software, and the statistics from each channel were exported to Microsoft Excel spreadsheets.
All statistical analyses were performed with GraphPad Prism v.6.0 and SAS v.9.4. Data are displayed as the mean ± SEM. Comparisons of means were analyzed with one-way ANOVA or two-tailed unpaired t test with Welch’s correction for non-equal variances. In certain experiments, two-way ANOVA was used for sex (male vs. female) and genotype (KO vs. SP-A1 vs. SP-A2), followed by planned comparisons using Fisher’s least significant difference. Comparisons of frequencies were performed with chi-square contingency analysis tests. In order to account for interindividual differences among the animals used in the study, a hierarchical analysis (animal–culture well–cell) was designed in the SAS software consisting of generalized linear mixed-effects models with Poisson regression. The models contain random effects to account for (1) the correlation due to measurements from the same animal, and for (2) similar environmental conditions within a well, followed by comparisons of genotype (or treatment, in the case of in vitro experiments) and phenotype, along with Bonferroni corrections for multiple comparisons. A P value ≤0.05 was considered statistically significant.
Cell area and F-actin content in the alveolar macrophages of humanized transgenic SP-A mice
In order to determine whether there are sex differences among the macrophages from different genetic backgrounds, we analyzed the same data taking into account the sex of the animals. Two-way ANOVA indicated that there is no sex-by-genotype interaction affecting the area of the macrophages (F(2,12) = 0.26, P = 0.7733). Sex was not found to be a factor that influences the area of AMs in old mice (F(1,12) = 0.1035, P = 0.4738). In accordance with previously demonstrated differences in AM size in response to SP-A1 or SP-A2 proteins in vitro , the main effect for genotype was significant (F(2,12) = 1.100, P = 0.0057). We used post hoc tests to compare the effects of SP-A1 and SP-A2 on the area of the AMs. In both males and females, the AM area of SP-A1 mice is significantly larger compared to that of KO. In SP-A1 males, the area is significantly larger than their SP-A2 counterparts. As far as the females are concerned, the only significant difference observed is between the SP-A1 and the KO mice (Fig. 1c). Interestingly, the significant difference in cell size observed between the SP-A2 and KO genotypes (Fig. 1a) is not reflected when the analysis includes the sex of the donor animals, because male SP-A2 AMs seemingly tend to be smaller than male KO cells, but AMs from female SP-A2 tend to occupy larger area. As far as the fluorescence intensity of F-actin is concerned, the interaction effect is significant (F(2,12) = 2.124, P < 0.00001). Fluorescence intensity is significantly higher in the SP-A1 male mice compared to KO males and SP-A2 males.
In order to determine whether the SP-A-induced changes in the alveolar macrophage cytoskeleton are innate to the mice or show as a cumulative result of the prolonged exposure to SP-A, we performed the same study using young (8 weeks old) animals, either KO or expressing SP-A1, SP-A2, or both (co-expressors). When the analysis is performed without factoring in the sex of the animals, there is no significant difference in the area of the alveolar macrophages among the different groups (Fig. 1e), but the F-actin fluorescence of the co-expressors was significantly reduced in comparison to the KO, SP-A1, and SP-A2 macrophages (Fig. 1f). However, there are significant differences in both area and actin fluorescence that are masked by the exclusion of sex as a factor, as can be seen in Fig. 1g, h. Two-way ANOVA with sex and genotype as the factors demonstrates that the sex-by-genotype interaction is significant for the cell area of the AMs (F(3,16) = 0.6264, P = 0.0285). Post hoc analysis reveals that the area of the macrophages of male mice expressing both SP-A1 and SP-A2 is significantly larger than the area of KO male, SP-A2 male, and SP-A1 male mice. Among female mice, the area of the macrophages from SP-A1 mice is significantly smaller than the area from the cells from all the other female mice. When comparing mice of opposite sex, while the KO and the SP-A2 macrophages do not have sex differences, the SP-A1 and the co-expressing female macrophages have significantly smaller area than the males of the same genetic background (Fig. 1g). There is no significant effect of the sex-by-genotype interaction on the F-actin fluorescence intensity (F(3,16) = 0.1969, P = 0.4029), but a significant effect was observed for each factor (for sex, P = 0.0001; for genotype, P < 0.0001). Post hoc tests show that the F-actin fluorescence intensity is strikingly reduced in both male and female co-expressing macrophages. With the exception of the co-expressing mice, there are no differences among the different genotypes within the same sex, but there is a significant increase in the staining intensity of the cytoskeleton of cells from female mice compared to male mice of the same background (Fig. 1h). The same tendency exists in both KO and co-expressing mice, but it does not reach significant levels.
Overall, these data confirm that the actin-related cytoskeleton of alveolar macrophages is affected by different SP-A variants in a complicated way and the effects of SP-A seem to accumulate over time. Previous work has shown that in vivo administration of SP-A1 to mice influenced the actin-related proteins of AMs from male and female mice differently , which is in accordance with the results presented here (Fig. 1d, g, and h). These results may have functional consequences, since the ratio of SP-A1 to total SP-A in BAL has been shown to change depending on age and on whether the patients suffer from pathologic conditions, such as cystic fibrosis and alveolar proteinosis , and asthma .
Subpopulations of alveolar macrophages based on the distribution of F-actin
Differences in the monomeric actin pools among the alveolar macrophage subpopulations
In vitro administration of SP-A proteins alters the alveolar macrophage subpopulations
Effects of SP-A1 and SP-A2 on the distribution of alveolar macrophage phenotypes
As far as the young mice are concerned (Fig. 5b), there is a baseline difference between the KO male and female mice, and this trend is opposite to the one in old mice. In the old KO mice, alveolar macrophages with high F-actin content (phenotypes “C” and “D”) are the prevalent phenotypes among males and less than 50 % among females. In the young KO male mice, phenotypes “C” and “D” combined account for ~42 % of the total number of macrophages. The same combination (“C” and “D”) for female mice is 65 %. SP-A2 (but not SP-A1) has an effect on male mice, while in female mice, each variant changes the distribution of AMs significantly. In addition, a significant difference is observed between SP-A1 and SP-A2 in female mice. As is the case with the old mice, there are no differences between the variants in male mice. When both SP-A1 and SP-A2 are expressed, the mice are similar to their KO counterparts, regardless of sex. Interestingly, there are still sex differences in the presence of either one or both variants. In the case of SP-A2, and the combination of both SP-A1 and SP-A2, the sex differences can be attributed to both the “A” and “D” phenotypes, whereas for SP-A1, only cells of the “A” phenotype are significantly different. No differences are observed among male mice that carry at least one SP-A variant, although the SP-A1 vs. SP-A2 P value is close to the level of significance, 0.05475. In females, the difference between the two variants shows statistical significance. At the same time, the distribution of cells from SP-A2 mice is similar to the one observed in SP-A1/SP-A2-expressing mice, meaning that the effect of SP-A2 is the major factor driving the observed phenotype.
In a series of studies, we have examined the effects of SP-A on the alveolar macrophage phenotype, as expressed by its cellular proteome, both in vitro and in vivo [14–17]. These studies revealed that the protein expression pattern of the alveolar macrophages is highly dependent on the microenvironment of the cells and the variant of SP-A involved is a major factor affecting the proteome. It was also demonstrated that there are significant sex differences in the response of alveolar macrophages after in vivo treatment of SP-A KO mice with SP-A from human bronchoalveolar lavage  or SP-A variants expressed in cell culture .
The studies mentioned above showed that the expression of proteins related with the actin cytoskeleton is affected by SP-A. Such proteins include, for instance, the F-actin capping protein, capping protein of the actin filament, the light chain of myosin, and the Rho GDP dissociation inhibitor, among others. Actin-related proteins are clearly of the utmost importance for the alveolar macrophages because many macrophage functions, such as motility, chemotaxis, and phagocytosis, are based on an intact cytoskeletal network with the potential for rapid remodeling.
The present study builds and expands on previous findings regarding the effects of SP-A on the actin cytoskeleton. Using an imaging approach, we determined the effect that SP-A1 and SP-A2 have on the alveolar macrophage phenotype, by studying the distribution of F-actin in the cells. In vitro assays with SP-A variants expressed by CHO cells and use of alveolar macrophages from humanized transgenic mice expressing SP-A1, SP-A2, or both revealed that (i) SP-A1 and SP-A2 differentially affect the alveolar macrophage subpopulations, (ii) the response to SP-A variants differs between males and females, and (iii) the response differs between young and old mice.
Initially, as a proof of concept, we used epifluorescence microscopy to determine whether there are any differences among the alveolar macrophages from mice of different genotypes and different ages, both male and female. It became evident that the phenotype and activation status of the alveolar macrophages, as demonstrated by the cell size and the F-actin mean per pixel fluorescence, is associated with the genotype of the donor animals. The results showed complicated response patterns, especially when factoring in the sex of the animals (Fig. 1). An important observation of this particular experiment was the diversity of phenotypes in the bronchoalveolar lavage cells under baseline conditions, even within the same field of view during imaging. Phalloidin staining of macrophages has been performed before, and the increase in cell size and/or the appearance of filopodia is indicative of macrophage activation, e.g., after LPS challenge [26, 27], while the polymerized actin in the unstimulated macrophages is perinuclear or cortical . It has been reported that M1-activated (pro-inflammatory) macrophages have a dense static actin network (similar to our observed phenotype “B”) whereas the actin of M2-activated (anti-inflammatory) macrophages is more diffuse and randomly distributed (similar to our observed phenotype “C”) . In a study that examined the effects of SP-A on the actin distribution of alveolar macrophages, it was reported that SP-A causes directional expansion of filopodia . Our confocal imaging experiments revealed distinct phenotypes that ranged from actin puncta (phenotype A), dense actin network (phenotype B), diffuse actin network (phenotype C), or protruding filopodia (phenotype D). We consider the distinct phenotypes as representing different stages of activation.
In order to understand whether the SP-A-induced phenotypic changes of the alveolar macrophages are related to rapid cytoskeletal remodeling or more permanent changes, we co-stained cells with fluorescent DNase I, which has been shown to bind to G-actin (monomeric) in the cytoplasm . Comparison of means of G-actin fluorescence units among the phenotypes revealed that the actin cytoplasmic pools follow a trend similar to the one of F-actin (F-/G-actin ratio is not significantly different among the observed phenotypes), indicating that the different phenotypes do not come as a result of rearrangement of the cytoskeleton but probably due to differences in the gene expression of actin itself as well as actin-related proteins. Thus, phenotype “A” is likely to represent cells that are detaching, presumably due to apoptosis, since the actin metabolism in these cells appears to be highly dynamic. Phenotype “B” is probably quiescent, whereas phenotypes “C” and “D” could represent early and late activation status, respectively.
In vitro administration of SP-A1 and SP-A2 proteins from the two SP-A genes to macrophages from SP-A KO mice altered the frequency of each phenotype. SP-A2 caused depolymerization of F-actin in cells from females, as demonstrated by the increase of phenotype A cells. When both SP-A1 and SP-A2 were used to treat AMs from KO mice, moderate effects were observed in both sexes compared to SP-A2 alone. This can be explained by the potential counterbalancing actions of SP-A1 and SP-A2. The higher proportion of activated alveolar macrophages from male mice exposed to SP-A2 (Fig. 4) is in accordance with a functional assay previously reported by our lab . In that study, alveolar macrophages from male rats were challenged with P. aeruginosa in the presence or absence of SP-A1 or SP-A2, and it was found that the phagocytic index of cells exposed to SP-A2 was higher than that of cells exposed to SP-A1.
The opposing actions of SP-A1 and SP-A2 are supported by the ex vivo results from the present study (Fig. 5). Cells isolated from young humanized transgenic male mice carrying SP-A1 did not show a significantly different phenotype distribution compared to KO, but cells from SP-A2 males showed a higher proportion of cells of the “C” and “D” phenotypes compared to KO, meaning that the macrophages of these mice are readily active. These results are consistent with our previous work  which showed that the proteome of macrophages from male mice is not as responsive to SP-A administration in vivo as females, as far as the actin-related group of proteins is concerned. Indeed, the present study verifies that in female mice, there is significant response to both SP-A1 and SP-A2 and this response is different between the two variants. However, co-expression of both variants counterbalances the effect and brings the cells to a distribution similar to the one observed in KO mice. Even though the distribution pattern is similar between the KO and the co-expressing cells, we speculate that these cells may be functionally distinct, with the cells exposed to SP-A1 and SP-A2 being primed for activation, whereas the KO cells may not. Further studies are needed to elucidate this.
Unlike the young male mice, cells isolated from older male transgenic mice were different from the KO. The punctate pattern of F-actin was more prominent in both SP-A1 and SP-A2 mice, with SP-A2 showing a higher proportion of cells with low actin levels. In older female mice, there are also gene-specific differences, with SP-A2 demonstrating more cells of the “C” phenotype and SP-A1 having higher proportion of the “D” phenotype. Aging has been reported to affect the immune system in general and macrophage functions in particular. Impairments of the immune system that are related to age (termed immunosenescence) seem to contribute to increased susceptibility to infectious diseases, as well as cancer and autoimmunity . In splenic macrophages, TLR4 signaling has been shown to be compromised during aging which leads to a perturbed pattern of cytokine expression [32, 33], although the exact molecular mechanisms are not well understood. Importantly, SP-A has been shown to directly interact with TLR4  and its co-receptor CD14  and modulates the TLR4 activity. Reduced expression of CD14 has been proposed as the reason for the impaired TLR4-related signaling during aging . Macrophage polarization towards the M1 and M2 phenotypes has also been reported to be affected by age. Although age does not result in a skew towards either phenotype , old mice seem to have higher numbers of M2 macrophages in the spleen, lymph nodes, and bone marrow . Interestingly, this observation could be in accordance with our study, if we consider alveolar macrophages of the “C” phenotype in the present study to be similar to M2 polarized, as described elsewhere [29, 38].
There are sex differences in the distribution of subpopulations of AMs among mice of the same genotype in both the in vitro (Fig. 4) and the ex vivo (Fig. 5) experiments. These results come as a continuation of a long series of studies that have demonstrated such differences in both the molecular and the physiological level [3, 4, 15, 17, 39, 40]. Hormonal regulation of the actin cytoskeleton in AMs could be an important factor in the generation of sex differences. Sex hormones have been shown to affect cytoskeletal proteins in other systems [41–43] and also the production of surfactant in the developing lung [44–46]. Whether sex hormones actually affect the cytoskeleton of AMs through SP-A or other mechanisms remains to be investigated.
Functionally, the regulation of the distribution of subpopulations of AMs by SP-A variants may explain differences observed in their phagocytic activity [11–13] and the course of lung disease [4, 39, 40, 47]. Sex differences concerning susceptibility in lung disease, such as asthma , chronic obstructive pulmonary disorder , and even lung cancer , have been widely reported, although the latter remains controversial . A more detailed analysis of the mechanisms governing the regulation of AM function by SP-A could provide clues to the development of individualized treatment according to a person’s genotype, as the AMs are the first line of defense. Such a treatment targets directly the AMs, and this could eliminate or minimize the need for intervention to activate the adaptive immune response, which would be even more complicated and perhaps more harmful to the host.
We examined the effects of surfactant proteins A1 and A2 on the alveolar macrophage phenotypes of male and female mice. Our results demonstrate that there are subpopulations of AMs as demonstrated by the actin cytoskeleton staining of the cells. Using humanized transgenic mice as a model, we showed that the exposure of AMs to SP-A1 or SP-A2 results in differential effects on macrophage phenotypes. These effects are ablated by exposure to both proteins, suggesting that these proteins exert opposing effects on the macrophages. Moreover, the phenotype responses of cells from male and female mice showed different responses to these proteins, a fact that should be examined more closely in the view of surfactant treatments. The age of the mice is also a major factor as it plays a role in the response of AMs to SP-A variant exposure. This indicates the importance of the SP-A genotype at the level of immune response compromises during aging. Our findings demonstrate the importance of SP-A in the immune response of the lung, but also illustrate the need for consideration of sex and age in studies that investigate lung immune responses and pathology.
(mouse) alveolar macrophage(s)
surfactant protein A
surfactant protein A1 gene
surfactant protein A2 gene
The authors would like to thank the Pennsylvania State University Core Facility and Dr. Thomas Abraham for the use of the SP8 confocal microscope and the IMARIS software. This work was funded in part by NIH (HL-34788).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Haque R, Umstead TM, Ponnuru P, Guo X, Hawgood S, Phelps DS, et al. Role of surfactant protein-A (SP-A) in lung injury in response to acute ozone exposure of SP-A deficient mice. Toxicol Appl Pharmacol. 2007;220(1):72–82. Epub 2007/02/20.View ArticlePubMedPubMed CentralGoogle Scholar
- Haque R, Umstead TM, Ahn K, Phelps DS, Floros J. Effect of low doses of lipopolysaccharide prior to ozone exposure on bronchoalveolar lavage: differences between wild type and surfactant protein A-deficient mice. Pneumon. 2009;22(2):143–55. Epub 2009/01/01.PubMedPubMed CentralGoogle Scholar
- Mikerov AN, Haque R, Gan X, Guo X, Phelps DS, Floros J. Ablation of SP-A has a negative impact on the susceptibility of mice to Klebsiella pneumoniae infection after ozone exposure: sex differences. Respir Res. 2008;9:77. Epub 2008/12/06.View ArticlePubMedPubMed CentralGoogle Scholar
- Mikerov AN, Hu S, Durrani F, Gan X, Wang G, Umstead TM, et al. Impact of sex and ozone exposure on the course of pneumonia in wild type and SP-A (-/-) mice. Microb Pathog. 2012;52(4):239–49. Epub 2012/01/31.View ArticlePubMedPubMed CentralGoogle Scholar
- LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol. 1998;19(4):700–8.View ArticlePubMedGoogle Scholar
- LeVine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. Surfactant protein A-deficient mice are susceptible to group B streptococcal infection. J Immunol. 1997;158(9):4336–40. Epub 1997/05/01.PubMedGoogle Scholar
- LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest. 1999;103(7):1015–21. Epub 1999/04/09.View ArticlePubMedPubMed CentralGoogle Scholar
- Wang G, Umstead TM, Phelps DS, Al-Mondhiry H, Floros J. The effect of ozone exposure on the ability of human surfactant protein a variants to stimulate cytokine production. Environ Health Perspect. 2002;110(1):79–84. Epub 2002/01/10.View ArticlePubMedPubMed CentralGoogle Scholar
- Huang W, Wang G, Phelps DS, Al-Mondhiry H, Floros J. Human SP-A genetic variants and bleomycin-induced cytokine production by THP-1 cells: effect of ozone-induced SP-A oxidation. Am J Physiol Lung Cell Mol Physiol. 2004;286(3):L546–53. Epub 2003/11/18.View ArticlePubMedGoogle Scholar
- Wang G, Bates-Kenney SR, Tao JQ, Phelps DS, Floros J. Differences in biochemical properties and in biological function between human SP-A1 and SP-A2 variants, and the impact of ozone-induced oxidation. Biochemistry. 2004;43(14):4227–39. Epub 2004/04/07.View ArticlePubMedGoogle Scholar
- Mikerov AN, Umstead TM, Gan X, Huang W, Guo X, Wang G, et al. Impact of ozone exposure on the phagocytic activity of human surfactant protein A (SP-A) and SP-A variants. Am J Physiol Lung Cell Mol Physiol. 2008;294(1):L121–30.View ArticlePubMedPubMed CentralGoogle Scholar
- Mikerov AN, Umstead TM, Huang W, Liu W, Phelps DS, Floros J. SP-A1 and SP-A2 variants differentially enhance association of Pseudomonas aeruginosa with rat alveolar macrophages. Am J Physiol Lung Cell Mol Physiol. 2005;288(1):L150–8. Epub 2004/09/21.View ArticlePubMedGoogle Scholar
- Mikerov AN, Wang G, Umstead TM, Zacharatos M, Thomas NJ, Phelps DS, et al. Surfactant protein A2 (SP-A2) variants expressed in CHO cells stimulate phagocytosis of Pseudomonas aeruginosa more than do SP-A1 variants. Infect Immun. 2007;75(3):1403–12.View ArticlePubMedPubMed CentralGoogle Scholar
- Phelps DS, Umstead TM, Quintero OA, Yengo CM, Floros J. In vivo rescue of alveolar macrophages from SP-A knockout mice with exogenous SP-A nearly restores a wild type intracellular proteome; actin involvement. Proteome Sci. 2011;9:67. Epub 2011/11/01.View ArticlePubMedPubMed CentralGoogle Scholar
- Phelps DS, Umstead TM, Floros J. Sex differences in the response of the alveolar macrophage proteome to treatment with exogenous surfactant protein-A. Proteome Sci. 2012;10(1):44. Epub 2012/07/25.View ArticlePubMedPubMed CentralGoogle Scholar
- Phelps DS, Umstead TM, Silveyra P, Hu S, Wang G, Floros J. Differences in the alveolar macrophage proteome in transgenic mice expressing human SP-A1 and SP-A2. J Proteom Genom Res. 2013;1(2):2–26. Epub 2014/04/15.View ArticlePubMedPubMed CentralGoogle Scholar
- Phelps DS, Umstead TM, Floros J. Sex differences in the acute in vivo effects of different human SP-A variants on the mouse alveolar macrophage proteome. J Proteome. 2014;108:427–44. Epub 2014/06/24.View ArticleGoogle Scholar
- Wang G, Guo X, Diangelo S, Thomas NJ, Floros J. Humanized SFTPA1 and SFTPA2 transgenic mice reveal functional divergence of SP-A1 and SP-A2: formation of tubular myelin in vivo requires both gene products. J Biol Chem. 2010;285(16):11998–2010. Epub 2010/01/06.View ArticlePubMedPubMed CentralGoogle Scholar
- Tagaram HR, Wang G, Umstead TM, Mikerov AN, Thomas NJ, Graff GR, et al. Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary health. Am J Physiol Lung Cell Mol Physiol. 2007;292(5):L1052–63. Epub 2006/12/26.View ArticlePubMedGoogle Scholar
- Wang Y, Voelker DR, Lugogo NL, Wang G, Floros J, Ingram JL, et al. Surfactant protein A is defective in abrogating inflammation in asthma. Am J Physiol Lung Cell Mol Physiol. 2011;301(4):L598–606. Epub 2011/07/26.View ArticlePubMedPubMed CentralGoogle Scholar
- Kuo HP, Yu CT. Alveolar macrophage subpopulations in patients with active pulmonary tuberculosis. Chest. 1993;104(6):1773–8. Epub 1993/12/01.View ArticlePubMedGoogle Scholar
- Brannen AL, Chandler DB. Alveolar macrophage subpopulations’ responsiveness to chemotactic stimuli. Am J Pathol. 1988;132(1):161–6. Epub 1988/07/01.PubMedPubMed CentralGoogle Scholar
- Zwilling BS, Campolito LB, Reiches NA. Alveolar macrophage subpopulations identified by differential centrifugation on a discontinuous albumin density gradient. Am Rev Respir Dis. 1982;125(4):448–52. Epub 1982/04/01.PubMedGoogle Scholar
- St-Laurent J, Turmel V, Boulet LP, Bissonnette E. Alveolar macrophage subpopulations in bronchoalveolar lavage and induced sputum of asthmatic and control subjects. J Asthma. 2009;46(1):1–8. Epub 2009/02/05.View ArticlePubMedGoogle Scholar
- Cramer LP, Briggs LJ, Dawe HR. Use of fluorescently labelled deoxyribonuclease I to spatially measure G-actin levels in migrating and non-migrating cells. Cell Motil Cytoskeleton. 2002;51(1):27–38. Epub 2002/01/26.View ArticlePubMedGoogle Scholar
- Singh PK, Venter G, Oerlemans FTJJ, Wijers M, Willemse M, Fransen JAM, et al. Glucose controls morphodynamics of LPS-stimulated macrophages. PLoS One. 2014;9(5), e96786.View ArticleGoogle Scholar
- Williams LM, Ridley AJ. Lipopolysaccharide induces actin reorganization and tyrosine phosphorylation of Pyk2 and paxillin in monocytes and macrophages. J Immunol. 2000;164(4):2028–36.View ArticlePubMedGoogle Scholar
- Zhang J, Zhu J, Bu X, Cushion M, Kinane TB, Avraham H, et al. Cdc42 and RhoB activation are required for mannose receptor-mediated phagocytosis by human alveolar macrophages. Mol Biol Cell. 2005;16(2):824–34. Epub 2004/12/03.View ArticlePubMedPubMed CentralGoogle Scholar
- Vogel DYS, Heijnen PDAM, Breur M, de Vries HE, Tool ATJ, Amor S, et al. Macrophages migrate in an activation-dependent manner to chemokines involved in neuroinflammation. J Neuroinflammation. 2014;11(1):23.View ArticlePubMedPubMed CentralGoogle Scholar
- Tino MJ, Wright JR. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages. Am J Physiol. 1999;276(1 Pt 1):L164–74. Epub 1999/01/14.PubMedGoogle Scholar
- Linehan E, Fitzgerald D. Ageing and the immune system: focus on macrophages. Eur J Microbiol Immunol. 2015;5(1):14–24.View ArticleGoogle Scholar
- Chelvarajan RL, Collins SM, Van Willigen JM, Bondada S. The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J Leukoc Biol. 2005;77(4):503–12. Epub 2005/01/05.View ArticlePubMedGoogle Scholar
- Chelvarajan RL, Liu Y, Popa D, Getchell ML, Getchell TV, Stromberg AJ, et al. Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages. J Leukoc Biol. 2006;79(6):1314–27. Epub 2006/04/11.View ArticlePubMedGoogle Scholar
- Yamada C, Sano H, Shimizu T, Mitsuzawa H, Nishitani C, Himi T, et al. Surfactant protein A directly interacts with TLR4 and MD-2 and regulates inflammatory cellular response. Importance of supratrimeric oligomerization. J Biol Chem. 2006;281(31):21771–80. Epub 2006/06/07.View ArticlePubMedGoogle Scholar
- Sano H, Chiba H, Iwaki D, Sohma H, Voelker DR, Kuroki Y. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem. 2000;275(29):22442–51. Epub 2000/05/10.View ArticlePubMedGoogle Scholar
- Mahbub S, Deburghgraeve CR, Kovacs EJ. Advanced age impairs macrophage polarization. J Interferon Cytokine Res. 2012;32(1):18–26. Epub 2011/12/20.View ArticlePubMedPubMed CentralGoogle Scholar
- Jackaman C, Radley-Crabb HG, Soffe Z, Shavlakadze T, Grounds MD, Nelson DJ. Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice. Aging Cell. 2013;12(3):345–57. Epub 2013/02/28.View ArticlePubMedGoogle Scholar
- McWhorter FY, Wang T, Nguyen P, Chung T, Liu WF. Modulation of macrophage phenotype by cell shape. Proc Natl Acad Sci. 2013;110(43):17253–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Mikerov AN, Cooper TK, Wang G, Hu S, Umstead TM, Phelps DS, et al. Histopathologic evaluation of lung and extrapulmonary tissues show sex differences in Klebsiella pneumoniae - infected mice under different exposure conditions. Int J Physiol Pathophysiol Pharmacol. 2011;3(3):176–90. Epub 2011/09/24.PubMedPubMed CentralGoogle Scholar
- Mikerov AN, Phelps DS, Gan X, Umstead TM, Haque R, Wang G, et al. Effect of ozone exposure and infection on bronchoalveolar lavage: sex differences in response patterns. Toxicol Lett. 2014;230(2):333–44. Epub 2014/04/29.View ArticlePubMedPubMed CentralGoogle Scholar
- Hansberg-Pastor V, Gonzalez-Arenas A, Pina-Medina AG, Camacho-Arroyo I. Sex hormones regulate cytoskeletal proteins involved in brain plasticity. Front Psychiatry. 2015;6:165. Epub 2015/12/05.View ArticlePubMedPubMed CentralGoogle Scholar
- Gonzalez-Arenas A, Pina-Medina AG, Gonzalez-Flores O, Galvan-Rosas A, Porfirio G-A, Camacho-Arroyo I. Sex hormones and expression pattern of cytoskeletal proteins in the rat brain throughout pregnancy. J Steroid Biochem Mol Biol. 2014;139:154–8. Epub 2013/01/16.View ArticlePubMedGoogle Scholar
- Wessel L, Olbrich L, Brand-Saberi B, Theiss C. New aspects of progesterone interactions with the actin cytoskeleton and neurosteroidogenesis in the cerebellum and the neuronal growth cone. J Histochem Cytochem. 2014;62(12):835–45. Epub 2014/08/22.View ArticlePubMedPubMed CentralGoogle Scholar
- Seaborn T, Simard M, Provost PR, Piedboeuf B, Tremblay Y. Sex hormone metabolism in lung development and maturation. Trends Endocrinol Metab. 2010;21(12):729–38. Epub 2010/10/26.View ArticlePubMedGoogle Scholar
- Massaro GD, Mortola JP, Massaro D. Sexual dimorphism in the architecture of the lung’s gas-exchange region. Proc Natl Acad Sci U S A. 1995;92(4):1105–7. Epub 1995/02/14.View ArticlePubMedPubMed CentralGoogle Scholar
- Bresson E, Seaborn T, Cote M, Cormier G, Provost PR, Piedboeuf B, et al. Gene expression profile of androgen modulated genes in the murine fetal developing lung. Reprod Biol Endocrinol. 2010;8:2. Epub 2010/01/13.View ArticlePubMedPubMed CentralGoogle Scholar
- Mikerov AN, White M, Hartshorn K, Wang G, Floros J. Inhibition of hemagglutination activity of influenza A viruses by SP-A1 and SP-A2 variants expressed in CHO cells. Med Microbiol Immunol. 2008;197(1):9–12. Epub 2007/05/24.View ArticlePubMedPubMed CentralGoogle Scholar
- Carey MA, Card JW, Voltz JW, Arbes Jr SJ, Germolec DR, Korach KS, et al. It’s all about sex: gender, lung development and lung disease. Trends Endocrinol Metab. 2007;18(8):308–13. Epub 2007/09/04.View ArticlePubMedPubMed CentralGoogle Scholar
- Raherison C, Tillie-Leblond I, Prudhomme A, Taille C, Biron E, Nocent-Ejnaini C, et al. Clinical characteristics and quality of life in women with COPD: an observational study. BMC Womens Health. 2014;14(1):31. Epub 2014/02/22.View ArticlePubMedPubMed CentralGoogle Scholar
- Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat. 2003;21(3):229–39. Epub 2003/03/06.View ArticlePubMedGoogle Scholar
- Prescott E, Osler M, Hein HO, Borch-Johnsen K, Lange P, Schnohr P, et al. Gender and smoking-related risk of lung cancer. The Copenhagen Center for Prospective Population Studies. Epidemiology. 1998;9(1):79–83. Epub 1998/01/16.View ArticlePubMedGoogle Scholar